Platform leverages muscle biology to de-risk development and identify new therapeutic targets ahead of clinical entry ...

Living alongside humans changed both how dogs behave and how they look. Research shows that domestic dogs developed a small ...

The company discontinued developing emugrobart after two studies showed the drug didn’t achieve intended outcomes.

Non-Muscle Invasive Bladder Cancer Market · GlobeNewswire Inc. The non-muscle invasive bladder cancer (NMIBC) market size has experienced robust growth, increasing from $3.66 billion in 2025 to an ...

A collage of dog food on a blue color background. Puppies are beyond the cutest things on this earth; you’re reading this ...

Chugai Pharmaceutical Co. fell 7.3%, the largest intraday decline since August 2025, after the company said it had ended the ...

Scientists from the University of California at Berkeley have discovered a neural circuit in the brain that synchronizes ...

PepGen’s lead candidate for myotonic dystrophy type 1 barely beat the placebo in a Phase 2 trial in terms of fixing incorrect ...

Driven by identity politics, Barak Valley is politically polarised this time between the BJP and the Congress, leaving little ...

The ACSM released new resistance training guidelines to improve muscle strength, size, and performance. medical News today ...

The big pharma company will no longer progress emugrobart to late-stage trials in FSHD and SMA due to a lack of efficacy.

Now to a major leap in the medical care of babies born with a devastating genetic condition. A diagnosis of type one spinal ...